New Key Statistics Module, Z-Score and F-Score
NAS:TBPH Key Ratios
| Market Cap $ M | 422.69 |
| Enterprise Value $ M | 372.78 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 139.35 |
| Price/Book | 2.18 |
| Price/Sales | 6.92 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 62.00 |
| EPS (TTM) $ | -0.92 |
| Beneish M-Score | -2.9 |
| 10-y EBITDA Growth Rate % | 14.90 |
| 5-y EBITDA Growth Rate % | 29.20 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -10.44 |
| EV-to-EBITDA | -11.95 |
| PEG | -- |
| Shares Outstanding M | 48.92 |
| Net Margin (%) | -73.61 |
| Operating Margin % | -62.82 |
| Pre-tax Margin (%) | -61.63 |
| Quick Ratio | 5.20 |
| Current Ratio | 5.20 |
| ROA % (ttm) | -11.55 |
| ROE % (ttm) | -20.06 |
| ROIC % (ttm) | -18.07 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.95 |
TBPH Number of Guru Trades
TBPH Volume of Guru Trades
Gurus Latest Trades with NAS:TBPH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TBPH is held by these investors
Total 1
Theravance Biopharma Inc Insider Transactions
No Available Data
News about NAS:TBPH
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers